0000920465-18-000029.txt : 20180820
0000920465-18-000029.hdr.sgml : 20180820
20180820210618
ACCESSION NUMBER: 0000920465-18-000029
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180816
FILED AS OF DATE: 20180820
DATE AS OF CHANGE: 20180820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rolke James
CENTRAL INDEX KEY: 0001693858
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 181029393
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
wf-form4_153481356291910.xml
FORM 4
X0306
4
2018-08-16
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001693858
Rolke James
C/O LA JOLLA PHARMACEUTICAL COMPANY,
4550 TOWNE CENTRE COURT
SAN DIEGO
CA
92121
0
1
0
0
Chief Scientific Officer
Common Stock
2018-08-16
4
P
0
1000
21.997
A
74328
D
/s/ Ryan Murr, as attorney-in-fact for James M. Rolke
2018-08-20